Andere talen HCW Biologics Inc.

Aandelen

HCWB

US40423R1059

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,647 ^USD	+1,08%		-35,30%	-47,18%

15/05	HCW Biologics Inc. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
01/04	HCW Biologics Inc. rapporteert winstcijfers voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

HCW Biologics Inc. announced that it expects to receive $10 million in funding	16/05
HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights	15/05
HCW Biologics Inc. Enters into A Senior Secured Note Purchase Agreement with Purchasers	01/05
HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
HCW Biologics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/04
HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights	01/04
HCW Biologics Inc. announced that it has received $2.500005 million in funding	20/02
HCW Biologics Inc. Exercises Its Right to Terminate Its Credit Agreement	12/01
HCW Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q3 Revenue $853,102	14/11
HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights	14/11
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting	08/11
HCW Biologics Inc. Announces Results from Preliminary Human Data Readout from an Ongoing Phase 1 Clinical Trial Sponsored by the University of Minnesota	08/11
HCW Biologics : First-in-Human Clinical Readout of HCW9218, SITC 2023	06/11
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting	01/11
HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023	06-09-23
HCW Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11-08-23
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q2 Revenue $622,807	11-08-23
HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights	11-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen HCW Biologics Inc.

Aandelen

HCWB

US40423R1059

Andere talen

Filters